Early development of the metabolic syndrome after chemotherapy for testicular cancer.
暂无分享,去创建一个
A. Smit | H. Boezen | A. V. van Roon | B. Wolffenbuttel | H. Hoekstra | S. Bakker | N. Zwart | F. V. van Leeuwen | J. Gietema | A. Smit | D. Sleijfer | E. C. de Haas | F. V. Leeuwen | A. Postma | A. M. Roon | D. Sleijfer | R. Altena | D. Haas | S. Bakker
[1] H. Seo,et al. Metabolic syndrome in adult cancer survivors: a meta-analysis. , 2012, Diabetes research and clinical practice.
[2] M. Wong,et al. Metformin in prostate cancer: two for the price of one. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] J. Vonk,et al. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer. , 2011, European Journal of Cancer.
[4] S. Fosså,et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Gietema,et al. Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro. , 2009, Oncology reports.
[6] A. Redig,et al. Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. , 2010, The American journal of medicine.
[7] A. Stopeck,et al. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. , 2009, Journal of women's health.
[8] G. Hankey,et al. Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. , 2009, European journal of endocrinology.
[9] H. Völzke,et al. Prediction of Metabolic Syndrome by Low Serum Testosterone Levels in Men , 2009, Diabetes.
[10] D. de Zeeuw,et al. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. , 2008, American journal of epidemiology.
[11] J. Schellens,et al. Long-term platinum retention after treatment with cisplatin and oxaliplatin , 2008, BMC clinical pharmacology.
[12] de Elisabeth G. E. Vries,et al. Systolic and diastolic dysfunction in childhood cancer survivors , 2008 .
[13] R. Gans,et al. Fasting insulin modifies the relation between age and renal function. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] Matthias W. Lorenz,et al. Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis , 2007, Circulation.
[15] P. Libby,et al. Intertwining of thrombosis and inflammation in atherosclerosis , 2007, Current opinion in hematology.
[16] S. Fosså,et al. Components of the metabolic syndrome in long-term survivors of testicular cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] C. Block,et al. Mechanisms linking obesity with cardiovascular disease , 2006, Nature.
[18] J. Després,et al. Abdominal obesity and metabolic syndrome , 2006, Nature.
[19] A. Dobs,et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] T. Travison,et al. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. , 2006, The Journal of clinical endocrinology and metabolism.
[21] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[22] F. V. van Leeuwen,et al. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] A. Smit,et al. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] T. Wilsgaard,et al. Blood pressure and body mass index in long-term survivors of testicular cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] A. Smit,et al. Left ventricular and cardiac autonomic function in survivors of testicular cancer , 2005, European journal of clinical investigation.
[26] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[27] Hiroyuki Ito,et al. Vitamin E prevents endothelial injury associated with cisplatin injection into the superior mesenteric artery of rats , 2005, Heart and Vessels.
[28] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[29] L. Niskanen,et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. , 2004, Diabetes care.
[30] A. V. van Roon,et al. Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. , 2004, European journal of cancer.
[31] D P Dearnaley,et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] S. Manuck,et al. Greater intima-media thickness in the carotid bulb is associated with reduced baroreflex sensitivity. , 2002, American journal of hypertension.
[33] D J van Veldhuisen,et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] D. Sleijfer,et al. Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer , 2000, The Lancet.
[35] P. Vermeulen,et al. In vitro toxicity studies with mitomycins and bleomycin on endothelial cells , 1997, Anti-cancer drugs.
[36] Decreased baroreflex sensitivity in patients with stable coronary artery disease is correlated with the severity of coronary narrowing. , 1996, The American journal of cardiology.
[37] I. Sartori. Increasing Prevalence of Overweight Among US Adults , 1996 .
[38] K. Flegal,et al. Increasing Prevalence of Overweight Among US Adults: The National Health and Nutrition Examination Surveys, 1960 to 1991 , 1994 .
[39] Giuseppe Mancia,et al. 1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting , 1993 .
[40] Lippincott Williams Wilkins,et al. 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. , 1993, Hypertension.
[41] E. D. de Vries,et al. Long-term Follow-up of Cardiovascular Risk Factors in Patients Given Chemotherapy for Disseminated Nonseminomatous Testicular Cancer , 1992, Annals of Internal Medicine.